Overexpression of FOS enhances the malignant potential of eutopic endometrial stromal cells in patients with endometriosis‑associated ovarian cancer

Junyu Chen & Manhua Cui et al. · 2025-02-21

1Citations
Endometrial cysts of the ovary (EMC) may develop into endometriosis (EM)‑associated ovarian cancer over time (EAOC), but the pathogenesis of this disease has not been determined. In the present study, RNA sequencing was used to identify a feasible biomarker, and the molecular function of this biomarker in eutopic endometrial cells from EAOC and EMC patients was evaluated to explore the potential mechanism related to EAOC and orthotopic endometrial tissue. RNA sequencing was performed on 5 EAOC and 4 EMC tissue samples, and differential expression analysis was performed. To identify biomarkers, differentially expressed genes were subjected to protein‑protein interaction network design, Gene Ontology pathway enrichment, and Gene Set Enrichment Analysis pathway enrichment. The expression of
TL;DR

Mitosis and the cell cycle were found to affect the progression of EMC to EAOC and the expression of FOS, a novel biomarker, was identified to enhance the malignant potential of eutopic endometrial stromal cells in patients with EM-associated ovarian cancer.

AI-generated by Semantic Scholar

Authors
Junyu Chen, Kang He, Xin Li, Mengqi Wang, Zhaoyun Yang, Zeyu Wang, Kai Wang, Weiqiang Jiang, Lijing Zhao, Manhua Cui